ethyl 2-(2,9,16,23-tetraoxo-1,10,13-triazatetracyclo[13.8.0.03,8.017,22]tricosa-3,5,7,17,19,21-hexaen-13-yl)acetate

C24H23N3O6 — CID 19704511

IUPACethyl 2-(2,9,16,23-tetraoxo-1,10,13-triazatetracyclo[13.8.0.03,8.017,22]tricosa-3,5,7,17,19,21-hexaen-13-yl)acetate
SMILESCCOC(=O)CN1CCNC(=O)c2ccccc2C(=O)N2C(=O)c3ccccc3C(=O)C2C1
InChIInChI=1S/C24H23N3O6/c1-2-33-20(28)14-26-12-11-25-22(30)16-8-4-6-10-18(16)24(32)27-19(13-26)21(29)15-7-3-5-9-17(15)23(27)31/h3-10,19H,2,11-14H2,1H3,(H,25,30)
InChIKeyQDSMDTHYXNDWFS-UHFFFAOYSA-N
MW449.46 g/mol
LogP1.14
Rot. Bonds3

About ethyl 2-(2,9,16,23-tetraoxo-1,10,13-triazatetracyclo[13.8.0.03,8.017,22]tricosa-3,5,7,17,19,21-hexaen-13-yl)acetate

ethyl 2-(2,9,16,23-tetraoxo-1,10,13-triazatetracyclo[13.8.0.03,8.017,22]tricosa-3,5,7,17,19,21-hexaen-13-yl)acetate (PubChem CID 19704511) has the molecular formula C24H23N3O6 and a molecular weight of 449.46 g/mol. Its IUPAC name is ethyl 2-(2,9,16,23-tetraoxo-1,10,13-triazatetracyclo[13.8.0.03,8.017,22]tricosa-3,5,7,17,19,21-hexaen-13-yl)acetate.

Molecular Properties

Compound Nameethyl 2-(2,9,16,23-tetraoxo-1,10,13-triazatetracyclo[13.8.0.03,8.017,22]tricosa-3,5,7,17,19,21-hexaen-13-yl)acetate
PubChem CID19704511
Molecular FormulaC24H23N3O6
Molecular Weight449.46 g/mol
Exact Mass449.16
IUPAC Nameethyl 2-(2,9,16,23-tetraoxo-1,10,13-triazatetracyclo[13.8.0.03,8.017,22]tricosa-3,5,7,17,19,21-hexaen-13-yl)acetate
SMILESCCOC(=O)CN1CCNC(=O)c2ccccc2C(=O)N2C(=O)c3ccccc3C(=O)C2C1
InChIInChI=1S/C24H23N3O6/c1-2-33-20(28)14-26-12-11-25-22(30)16-8-4-6-10-18(16)24(32)27-19(13-26)21(29)15-7-3-5-9-17(15)23(27)31/h3-10,19H,2,11-14H2,1H3,(H,25,30)
InChIKeyQDSMDTHYXNDWFS-UHFFFAOYSA-N
XLogP1.14
TPSA113.09 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds3
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500449.46
LogP ≤ 51.14
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze ethyl 2-(2,9,16,23-tetraoxo-1,10,13-triazatetracyclo[13.8.0.03,8.017,22]tricosa-3,5,7,17,19,21-hexaen-13-yl)acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of ethyl 2-(2,9,16,23-tetraoxo-1,10,13-triazatetracyclo[13.8.0.03,8.017,22]tricosa-3,5,7,17,19,21-hexaen-13-yl)acetate?
The IUPAC name of ethyl 2-(2,9,16,23-tetraoxo-1,10,13-triazatetracyclo[13.8.0.03,8.017,22]tricosa-3,5,7,17,19,21-hexaen-13-yl)acetate (CID 19704511) is ethyl 2-(2,9,16,23-tetraoxo-1,10,13-triazatetracyclo[13.8.0.03,8.017,22]tricosa-3,5,7,17,19,21-hexaen-13-yl)acetate.
What is the SMILES notation for ethyl 2-(2,9,16,23-tetraoxo-1,10,13-triazatetracyclo[13.8.0.03,8.017,22]tricosa-3,5,7,17,19,21-hexaen-13-yl)acetate?
The canonical SMILES for ethyl 2-(2,9,16,23-tetraoxo-1,10,13-triazatetracyclo[13.8.0.03,8.017,22]tricosa-3,5,7,17,19,21-hexaen-13-yl)acetate is CCOC(=O)CN1CCNC(=O)c2ccccc2C(=O)N2C(=O)c3ccccc3C(=O)C2C1.
What is the InChIKey of ethyl 2-(2,9,16,23-tetraoxo-1,10,13-triazatetracyclo[13.8.0.03,8.017,22]tricosa-3,5,7,17,19,21-hexaen-13-yl)acetate?
The InChIKey is QDSMDTHYXNDWFS-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H23N3O6/c1-2-33-20(28)14-26-12-11-25-22(30)16-8-4-6-10-18(16)24(32)27-19(13-26)21(29)15-7-3-5-9-17(15)23(27)31/h3-10,19H,2,11-14H2,1H3,(H,25,30).
What are the key properties of ethyl 2-(2,9,16,23-tetraoxo-1,10,13-triazatetracyclo[13.8.0.03,8.017,22]tricosa-3,5,7,17,19,21-hexaen-13-yl)acetate?
ethyl 2-(2,9,16,23-tetraoxo-1,10,13-triazatetracyclo[13.8.0.03,8.017,22]tricosa-3,5,7,17,19,21-hexaen-13-yl)acetate has a molecular weight of 449.46 g/mol, XLogP of 1.14, 3 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for ethyl 2-(2,9,16,23-tetraoxo-1,10,13-triazatetracyclo[13.8.0.03,8.017,22]tricosa-3,5,7,17,19,21-hexaen-13-yl)acetate is sourced from PubChem (CID 19704511), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).